Tag results:
STAT5
Immunology of Infectious Disease News
HIV-1 Vpr Drives a Tissue Residency-Like Phenotype during Selective Infection of Resting Memory T Cells
[Cell Reports] Investigators showed that HIV-1 cell-to-cell spread permited efficient, productive infection of resting memory T cells without prior activation.
Immunology of Infectious Disease News
HIV-1 Vpr Drives a Tissue Residency-Like Phenotype during Selective Infection of Resting Memory T Cells
[Cell Reports] Investigators showed that HIV-1 cell-to-cell spread permited efficient, productive infection of resting memory T cells without prior activation.
Prostate Cell News
GH Action in Prostate Cancer Cells Promotes Proliferation Limits Apoptosis and Regulates Cancer-Related Gene Expression
[Endocrinology] The authors addressed the species specificity of growth hormone (GH)-GH receptor activity by investigating GH actions in prostate cancer cell lines derived from a mouse Pten deletion model.
Hepatic Cell News
Ablation of Cbl-B and C-cbl in Dendritic Cells Causes Spontaneous Liver Cirrhosis via Altering Multiple Properties of CD103+ cDC1s
[Cell Death Discovery] Scientists found that specific deletion of Cbl-b and c-Cbl in CD11c+ cells, predominantly in dendritic cells (DCs), led to liver fibrosis, cirrhosis, and accumulation of systemic conventional Type I DCs due to enhanced cell proliferation and decreased cell apoptosis.
Hematopoiesis News
Preclinical and Pilot Study of Type I FLT3 Tyrosine Kinase Inhibitor, Crenolanib, with Sorafenib in Acute Myeloid Leukemia and FLT3-Internal Tandem Duplication
[Clinical Cancer Research] The combination of crenolanib and sorafenib was tolerable with antileukemic activities and rare emergence of FLT3-TKD mutations, which warrants further investigation.
Hematopoiesis News
The Role of the Atypical Chemokine Receptor CCRL2 in Myelodysplastic Syndrome and Secondary Acute Myeloid Leukemia
[Science Advances] Investigators revealed that CCRL2 was up-regulated in primitive cells from patients with myelodysplastic syndrome and secondary AML.